Pilot Study for Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Results of induction therapy,Distribution of entry criteria,Treatment feasibility,Relapse rate and localisation,Death in CR,Remission duration, survival and leukemia free survival,Prognostic factors,Quality of life
Dieter Hoelzer, MD
Study Chair
University Hospital Frankfurt, Medical Dept. II
Germany: Federal Institute for Drugs and Medical Devices
GMALL11
NCT00199095
February 1997
Name | Location |
---|